STRUCTURE MODIFICATIONS AND THEIR INFLUENCES ON ANTITUMOR AND OTHER RELATED ACTIVITIES OF TAXOL AND ITS ANALOGS - Medicinal Chemistry of Bioactive Natural Products - page 138

206. Kan, P.; Chen, Z. B.; Lee, C. J.; Chu, I. M. Development of nonionic surfactant/
phospolipid o/w emulsion as a paclitaxel delivery system. J. Controlled Release, 1999,
58: 271-278.
207. Crosasso, P.; Ceruti, M.; Brusa, P.; Arpicco, S.; Dosio, F.; Cattel, L. Preparation,
characterization and properties of sterically stabilized paclitaxel-containing liposomes.
J. Controlled Release, 2000, 63: 19-30.
208. Ceruti, M.; Crosasso, P.; Brusa, P.; Arpicco, S.; Dosio, F.; Cattel, L. Preparation,
characterization and properties in vitro and in vivo of liposomes containing water-
soluble prodrugs of paclitaxel. J. Controlled Release, 2000, 63: 141-153.
209. Paradis, R.; Page, M. New active paclitaxel amino acids derivatives with improved water
solubility. Anticancer Res., 1998, 18: 2711-2716.
210. Li, C.; Yu, D.-F.; Newman, R. A.; Cabral, F.; Stephens, L. C.; Milas, L.; Wallace, S.
Complete regression of well-established tumors using a novel water-soluble poly(L-
glutamic acid)-paclitaxel conjugate. Cancer Res., 1998, 58: 2404-2409.
211. Li, C.; Price, J. E.; Milas, L.; Hunter, N. R.; Ke, S.; Yu, D.-F.; Charnsangavej, C.;
Wallace, S. Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and
xenografted tumors. Clin. Cancer Res., 1999, 5: 891-897.
212. Damen, E. W. P.; Wiegerinck, P. H. G.; Braamer, L.; Sperling, D.; de Vos, D.; Scheeren,
H. W. Paclitaxel esters of malic acid as prodrugs with improved water solubility. Bioorg.
Med. Chem., 2000, 8: 427-432.
213. Niethammer, A.; Gaedicke, G.; Lode, H. N.; Wrasidlo, W. Synthesis and preclinical
characterization of a paclitaxel prodrug with improved antitumor activity and water
solubility. Bioconjugate Chem., 2001, 12: 414-420.
214. Seligson, A. L.; Terry, R. C.; Brssi, J. C. Dougalss, J. G., III; Sovak, M. A new prodrug of
paclitaxel: synthesis of protaxel. Anti-Cancer Drugs, 2001, 12: 305-313.
215. Hwu, J. R.; Tsay, S.-C.; Sambaiah, T.; Lai, Y.-K.; Lieu, C.-H.; Hakimelahi, G. H.; King,
K.-Y. Design and synthesis of paclitaxel-containing aminoester phosphate and phos-
phoamidate. Mendeleev Commun., 2001, 216.
216. Takahashi, T.; Tsukamoto, H.; Yamaka, H. Design and synthesis of a water-soluble taxol
analgoue: taxol-sialyl conjugate. Bioorg. Med. Chem. Lett., 1998, 8: 113-116.
217. Greenwald, R. B.; Pendri, A.; Bolikal, D.; Gilbert, C. W. Highly water soluble taxol
derivatives: 2 0 -polyethyleneglycol esters as potential prodrugs. Bioorg. Med. Chem.
Lett., 1994, 4: 2465-2470.
218. Greenwald, R. B.; Gilbert, C. W.; Pendri, A.; Conover, C. D.; Xia, J.; Martinez, A. Drug
delivery systems: water soluble taxol 2 0 -poly(ethylene glycol) ester prodrugs—design
and in vivo effectiveness. J. Med. Chem., 1996, 39: 424-431.
219. Feng, X.; Yuan, Y.-J.; Wu, J.-C. Synthesis and evaluation of water-soluble paclitaxel
prodrugs. Bioorg. Med. Chem. Lett., 2002, 12: 3301-3303.
220. Paradis, R.; Page, M. New active paclitaxel glucuronide derivative with improved water
solubility. Int. J. Oncol., 1998, 12: 391-394.
221. Pendri, A.; Conover, C. D.; Greenwald, R. B. Antitumor activity of paclitaxel-2 0 -
glycinate conjugated to poly(ethylene glycol): a water-soluble prodrug. Anti-Cancer
Drug Des., 1998, 13: 387-395.
222. Dosio, F.; Arpicco, S.; Brusa, P.; Stella, B.; Cattel, L. Poly(ethylene glycol)-human
serum albumin-paclitaxel conjugates: preparation, characterization and pharmacoki-
netics. J. Controlled Release, 2001; 76: 107-117.